Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics.... Show more
Segments: Established Pharmaceutical Products; Diagnostic Products; Nutritional Products; Cardiovascular; Neuromodulation Products; Other
Rating: Strong Buy

Abbott Laboratories Financial Health

Profitability:5.92/10

Abbott Laboratories has better Profitability than 55.56% of the companies on the Drug Manufacturers industry

Net Margin: 9.89%

Abbott Laboratories has worst Net Margin than 50% of the companies on the Drug Manufacturers industry


ROE (Return on Equity): 2.51%

Abbott Laboratories has better ROE (Return on Equity) than 55.56% of the companies on the Drug Manufacturers industry


ROA (Return on Assets): 1.14%

Abbott Laboratories has worst ROA (Return on Assets) than 50% of the companies on the Drug Manufacturers industry


Operating Efficiency:6.38/10

Abbott Laboratories has worst Operating Efficiency than 66.67% of the companies on the Drug Manufacturers industry

Operating Margin: 12.19%

Abbott Laboratories has worst Operating Margin than 66.67% of the companies on the Drug Manufacturers industry


Liquidity:4.72/10

Abbott Laboratories has better Liquidity than 58.33% of the companies on the Drug Manufacturers industry

Quick Ratio: 1.1

Abbott Laboratories has better Quick Ratio than 58.33% of the companies on the Drug Manufacturers industry


Operating Cash Flow Ratio: 0.58

Abbott Laboratories has worst Operating Cash Flow Ratio than 50% of the companies on the Drug Manufacturers industry


Solvency:6.42/10

Abbott Laboratories has worst Solvency than 50% of the companies on the Drug Manufacturers industry

Debt to Equity Ratio: 0.64

Abbott Laboratories has better Debt to Equity Ratio than 66.67% of the companies on the Drug Manufacturers industry


Interest Coverage Ratio: 0.58

Abbott Laboratories has worst Interest Coverage Ratio than 50% of the companies on the Drug Manufacturers industry


Abbott Laboratories revenue quarter by quarter
Abbott Laboratories operating expenses

👀 Get a summary of every week for free

Top company news, earnings report, analysis and more.

InspectCompany.com

We aim to help investors learn more about the companies in which they invest. We believe investing should be less about trying to find patterns in charts and more about investing in the companies that better represent your vision for the future.

Disclaimer: InspectCompany does not guarantee that any of the information available on our website, APIs or provided by any other means is complete, accurate, current, reliable or appropriate for your needs. Some of our information is provided by third party services and we cannot guarantee that is complete, accurate, current, reliable or appropriate for your needs. The information and recommendations on this site are for educational purposes only and should not be used to replace the advice of financial advisors and other professionals. All our services, information, data and/or recommendations are provided on an "as is" basis and without warranties of any kind, either express or implied. We do not guarantee that our services, information, data and/or recommendations are complete, accurate, current, reliable or appropriate for your needs.  Read more